According to Sutro Biopharma's latest financial reports the company's current EPS (TTM) is -$2.47. In 2022 the company made an earnings per share (EPS) of -$2.37 a decrease over its 2021 EPS that were of -$2.29.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.47 | 4.22% |
2022 | -$2.37 | 3.49% |
2021 | -$2.29 | 78.91% |
2020 | -$1.28 | -47.11% |
2019 | -$2.42 | -12.2% |
2018 | -$2.76 |